S|P|O
RUNX2|subClassOf|gene
COL10A1|subClassOf|gene
RUNX2|causes or contributes to condition|Osteosarcoma
VEGFA|causes or contributes to condition|Osteosarcoma
MMP13|subClassOf|gene
valproic acid|interacts with|RUNX2
valproic acid|interacts with|CEBPB
COL10A1|participates_in|Extracellular matrix organization
DDR2 (human)|participates_in|Extracellular matrix organization
COL10A1|participates_in|Collagen chain trimerization
COL3A1|participates_in|Collagen chain trimerization
COL1A1|participates_in|Collagen chain trimerization
COL2A1|participates_in|Collagen chain trimerization
VEGFA|subClassOf|gene
COL10A1|participates_in|Assembly of collagen fibrils and other multimeric structures
MMP13|participates_in|Assembly of collagen fibrils and other multimeric structures
COL10A1|subClassOf|protein_coding_gene
CEBPB|subClassOf|protein_coding_gene
MMP13|causes or contributes to condition|Prostate neoplasm
VEGFA|causes or contributes to condition|Prostate neoplasm
MMP13|subClassOf|protein_coding_gene
DIO2|has gene product|type II iodothyronine deiodinase (human)
Triiodothyronine|interacts with|type II iodothyronine deiodinase (human)
EPAS1|participates_in|Cellular responses to stress
CEBPB|participates_in|Cellular responses to stress
ARNT|subClassOf|protein_coding_gene
GANC|subClassOf|protein_coding_gene
ARNT|causes or contributes to condition|Cutaneous melanoma
COL2A1|causes or contributes to condition|Cutaneous melanoma
ARNT|participates_in|Metabolism
ACAN|participates_in|Metabolism
ARNT|participates_in|Regulation of gene expression by Hypoxia-inducible Factor
VEGFA|participates_in|Regulation of gene expression by Hypoxia-inducible Factor
HIF1A|participates_in|Regulation of gene expression by Hypoxia-inducible Factor
COL2A1|subClassOf|protein_coding_gene
ACAN|subClassOf|protein_coding_gene
VEGFA|subClassOf|protein_coding_gene
COL2A1|participates_in|Extracellular matrix organization
COL2A1|causes or contributes to condition|Cleft palate
SOX9|causes or contributes to condition|Cleft palate
aggrecan core protein (human)|participates_in|Extracellular matrix organization
aggrecan core protein (human)|subClassOf|AGC
ACAN|participates_in|Extracellular matrix organization
COL2A1|causes or contributes to condition|Multiple epiphyseal dysplasia
VEGFA|causes or contributes to condition|Multiple epiphyseal dysplasia
ACAN|subClassOf|gene
VEGFA|participates_in|VEGF binds to VEGFR leading to receptor dimerization
KDR|participates_in|VEGF binds to VEGFR leading to receptor dimerization
HIF1A|subClassOf|protein_coding_gene
valproic acid|interacts with|HIF1A
valproic acid|interacts with|COL2A1
HIF1A|participates_in|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
VHL|participates_in|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
Triiodothyronine|is substance that treats|nevus of Ito
nevus of Ito|has phenotype|Pulmonary arterial hypertension
EPAS1|causes or contributes to condition|Pulmonary arterial hypertension
valproic acid|interacts with|P4HTM (human)
aflatoxin B1|interacts with|CNMD (human)
aflatoxin B1|interacts with|EPAS1
KDR|causes or contributes to condition|tubular adenocarcinoma
PIK3CA|causes or contributes to condition|tubular adenocarcinoma
KDR|participates_in|VEGFR2 mediated cell proliferation
MAPK3|participates_in|VEGFR2 mediated cell proliferation
MAPK1|participates_in|VEGFR2 mediated cell proliferation
KDR|causes or contributes to condition|Deep venous thrombosis
JAK2|causes or contributes to condition|Deep venous thrombosis
PRKCA (human)|participates_in|VEGFR2 mediated cell proliferation
KDR|causes or contributes to condition|Schizophrenia
RELA|causes or contributes to condition|Schizophrenia
NFKB1|causes or contributes to condition|tubular adenocarcinoma
KDR|subClassOf|protein_coding_gene
RELB|subClassOf|protein_coding_gene
JUND|subClassOf|protein_coding_gene
KDR|causes or contributes to condition|Lung adenocarcinoma
JUNB|causes or contributes to condition|Lung adenocarcinoma
FOS|subClassOf|protein_coding_gene
KDR|causes or contributes to condition|Angiosarcoma
JUN|causes or contributes to condition|Angiosarcoma
FOSL2|subClassOf|protein_coding_gene
FOSL1|subClassOf|protein_coding_gene
FOSB|subClassOf|protein_coding_gene
KDR|causes or contributes to condition|Neoplasm of the pancreas
HIF1A|causes or contributes to condition|Neoplasm of the pancreas
PIK3CA|participates_in|CD28 dependent PI3K/Akt signaling
AKT1|participates_in|CD28 dependent PI3K/Akt signaling
AKT2|participates_in|CD28 dependent PI3K/Akt signaling
PIK3CA|causes or contributes to condition|Hemimegalencephaly
AKT3|causes or contributes to condition|Hemimegalencephaly
NGF|participates_in|TRKA activation by NGF
NTRK1|participates_in|TRKA activation by NGF
NGF|has gene product|beta-nerve growth factor (human)
beta-nerve growth factor (human)|molecularly interacts with|angiopoietin-1 receptor (human)
angiopoietin-1 receptor (human)|participates_in|Endothelial cell proliferation
NGF|participates_in|NRAGE signals death through JNK
Bcl-2-like protein 11 (human)|participates_in|NRAGE signals death through JNK
Bcl-2-like protein 11 (human)|participates_in|Tube formation
NTRK1|causes or contributes to condition|Lewy bodies
autosomal recessive juvenile Parkinson disease 2|has phenotype|Lewy bodies
RAS|is substance that treats|autosomal recessive juvenile Parkinson disease 2
oxygen atom|is substance that treats|Hypoxemia
oxygen atom|interacts with|HIF1A
desiccated thyroid extract|has part|L-thyroxine
desiccated thyroid extract|has part|Triiodothyronine
hormone|molecularly interacts with|Endothelial cell proliferation
hormone|molecularly interacts with|Tube formation
JUND|causes or contributes to condition|Cirrhosis
CCN2|causes or contributes to condition|Cirrhosis
JUND|causes or contributes to condition|Status epilepticus without prominent motor symptoms
NGF|causes or contributes to condition|Status epilepticus without prominent motor symptoms
JUNB|causes or contributes to condition|Status epilepticus without prominent motor symptoms
FOS|causes or contributes to condition|Status epilepticus without prominent motor symptoms
JUN|causes or contributes to condition|Status epilepticus without prominent motor symptoms
JUND|causes or contributes to condition|Neoplasm of the lung
FOSL2|causes or contributes to condition|Neoplasm of the lung
FOSB|causes or contributes to condition|Neoplasm of the lung
CCN2|participates_in|PPARA activates gene expression
apolipoprotein A-I (human)|participates_in|PPARA activates gene expression
apolipoprotein A-I (human)|participates_in|Endothelial cell proliferation
valproic acid|interacts with|CCN2
valproic acid|molecularly interacts with|Tube formation
JUNB|causes or contributes to condition|Neoplasm of the lung
CCN2|causes or contributes to condition|Neoplasm of the lung
JUNB|causes or contributes to condition|middle cerebral artery infarction
NGF|causes or contributes to condition|middle cerebral artery infarction
FOS|causes or contributes to condition|middle cerebral artery infarction
JUNB|subClassOf|protein_coding_gene
FOS|causes or contributes to condition|Extrahepatic cholestasis
CCN2|causes or contributes to condition|Extrahepatic cholestasis
FOS|participates_in|Activation of the AP-1 family of transcription factors
JUN|participates_in|Activation of the AP-1 family of transcription factors
FOS|causes or contributes to condition|Neoplasm of the lung
FOS|causes or contributes to condition|Focal sensory seizure
FOSB|causes or contributes to condition|Focal sensory seizure
JUN|causes or contributes to condition|Extrahepatic cholestasis
JUN|causes or contributes to condition|Neoplasm of the lung
JUN|subClassOf|protein_coding_gene
JUN|causes or contributes to condition|Neoplasm of the liver
FOSB|causes or contributes to condition|Neoplasm of the liver
aflatoxin B1|interacts with|FOSL2
aflatoxin B1|interacts with|NGF
CCN2|subClassOf|protein_coding_gene
NGF|subClassOf|protein_coding_gene
FOSB|causes or contributes to condition|Seizure
NGF|causes or contributes to condition|Seizure
RELA|causes or contributes to condition|Breast carcinoma
IBSP|causes or contributes to condition|Breast carcinoma
RELA|causes or contributes to condition|Brain neoplasm
SPP1|causes or contributes to condition|Brain neoplasm
RELA|participates_in|Signaling by Interleukins
VEGFA|participates_in|Signaling by Interleukins
RELA|causes or contributes to condition|Extrahepatic cholestasis
RELA|participates_in|NF-kB is activated and signals survival
NGF|participates_in|NF-kB is activated and signals survival
RELA|participates_in|IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
NFKB1|participates_in|IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
RELA|participates_in|CD209 (DC-SIGN) signaling
RELB|participates_in|CD209 (DC-SIGN) signaling
IBSP|participates_in|Extracellular matrix organization
lysyl oxidase homolog 2 (human)|participates_in|Extracellular matrix organization
lysyl oxidase homolog 2 (human)|participates_in|Endothelial cell proliferation
polycyclic arene|is substance that treats|Breast carcinoma
polycyclic arene|molecularly interacts with|Tube formation
IBSP|participates_in|Integrin cell surface interactions
SPP1|participates_in|Integrin cell surface interactions
SPP1|participates_in|Degradation of the extracellular matrix
matrix metalloproteinase-14 (human)|participates_in|Degradation of the extracellular matrix
matrix metalloproteinase-14 (human)|participates_in|Endothelial cell proliferation
SPP1|causes or contributes to condition|Carotid artery stenosis
bisphenol A|is substance that treats|Carotid artery stenosis
bisphenol A|molecularly interacts with|Tube formation
NFKB1|subClassOf|protein_coding_gene
IBSP|subClassOf|protein_coding_gene
SPP1|causes or contributes to condition|tubular adenocarcinoma
VEGFA|causes or contributes to condition|tubular adenocarcinoma
CCN2|causes or contributes to condition|tubular adenocarcinoma
NFKB1|participates_in|NF-kB is activated and signals survival
NFKB1|participates_in|CD209 (DC-SIGN) signaling
SPP1|subClassOf|protein_coding_gene
RELB|participates_in|Cytokine Signaling in Immune system
VEGFA|participates_in|Cytokine Signaling in Immune system
MAPK3|causes or contributes to condition|Neoplasm of the lung
SOX9|causes or contributes to condition|Neoplasm of the lung
MAPK3|participates_in|Disease
aggrecan core protein (human)|participates_in|Disease
valproic acid|interacts with|MAPK3
MAPK3|participates_in|Gene expression (Transcription)
RUNX2|participates_in|Gene expression (Transcription)
MAPK3|subClassOf|protein_coding_gene
MAPK3|causes or contributes to condition|malignant tumor of neck
VEGFA|causes or contributes to condition|malignant tumor of neck
MAPK3|causes or contributes to condition|Prostate cancer
MMP13|causes or contributes to condition|Prostate cancer
MAPK3|participates_in|Negative feedback regulation of MAPK pathway
MAPK1|participates_in|Negative feedback regulation of MAPK pathway
MAPK1|causes or contributes to condition|Neoplasm of the lung
MAPK1|participates_in|Disease
valproic acid|interacts with|MAPK1
MAPK1|subClassOf|protein_coding_gene
MAPK1|causes or contributes to condition|malignant tumor of neck
JAK2|participates_in|Interleukin-6 signaling
STAT3|participates_in|Interleukin-6 signaling
FGFR1|participates_in|PI-3K cascade:FGFR1
PIK3CA|participates_in|PI-3K cascade:FGFR1
hypogonadotropic hypogonadism 2 with or without anosmia|disease has basis in dysfunction of|FGFR1
hypogonadotropic hypogonadism 2 with or without anosmia|has phenotype|Orthostatic hypotension
RAS|is substance that treats|Orthostatic hypotension
FGFR1|causes or contributes to condition|Jackson-Weiss syndrome
FGFR2|causes or contributes to condition|Jackson-Weiss syndrome
FGFR1|causes or contributes to condition|gliosarcoma
FGFR3|causes or contributes to condition|gliosarcoma
FGFR1|participates_in|PI3K Cascade
FGFR4|participates_in|PI3K Cascade
LAMTOR1|participates_in|PI3K Cascade
FGFR2|participates_in|PI-3K cascade:FGFR2
PIK3CA|participates_in|PI-3K cascade:FGFR2
FGFR2|participates_in|RET signaling
glial cell line-derived neurotrophic factor (human)|participates_in|RET signaling
RAS|interacts with|glial cell line-derived neurotrophic factor (human)
FGFR2|causes or contributes to condition|LADD syndrome
FGFR3|causes or contributes to condition|LADD syndrome
FGFR2|participates_in|PI3K Cascade
FGFR3|causes or contributes to condition|Epidermal nevus
PIK3CA|causes or contributes to condition|Epidermal nevus
FGFR3|causes or contributes to condition|testicular germ cell tumor
testicular germ cell tumor|has phenotype|Orthostatic hypotension
FGFR3|participates_in|PI3K Cascade
FGFR4|participates_in|Signaling by FGFR4 in disease
PIK3CA|participates_in|Signaling by FGFR4 in disease
FGFR4|participates_in|RET signaling
PIK3CA|participates_in|PI3K Cascade
LAMTOR1|participates_in|Signal Transduction
glial cell line-derived neurotrophic factor (human)|participates_in|Signal Transduction
MAPK1|participates_in|RET signaling
MAPK3|participates_in|RET signaling
AKT1|causes or contributes to condition|Osteosarcoma
AKT1|subClassOf|gene
AKT1|causes or contributes to condition|Prostate neoplasm
AKT1|participates_in|Deactivation of the beta-catenin transactivating complex
SOX9|participates_in|Deactivation of the beta-catenin transactivating complex
AKT1|participates_in|Disease
COL2A1|subClassOf|gene
AKT1|participates_in|AKT-mediated inactivation of FOXO1A
AKT2|participates_in|AKT-mediated inactivation of FOXO1A
AKT3|participates_in|AKT-mediated inactivation of FOXO1A
AKT2|participates_in|Generic Transcription Pathway
RUNX2|participates_in|Generic Transcription Pathway
AKT2|subClassOf|gene
AKT2|participates_in|VEGFA-VEGFR2 Pathway
VEGFA|participates_in|VEGFA-VEGFR2 Pathway
AKT2|participates_in|Deactivation of the beta-catenin transactivating complex
AKT2|participates_in|Disease
AKT3|participates_in|Generic Transcription Pathway
AKT3|subClassOf|gene
AKT3|participates_in|VEGFA-VEGFR2 Pathway
SOX9|subClassOf|gene
AKT3|participates_in|Disease
AKT3|causes or contributes to condition|Cutaneous melanoma
SOX9|has gene product|transcription factor SOX-9 (human)
transcription factor SOX-9 (human)|molecularly interacts with|aggrecan core protein (human)
aggrecan core protein (human)|molecularly interacts with|transcription factor SOX-9 (human)
transcription factor SOX-9 (human)|has_gene_template|SOX9
FGF23|participates_in|FGFR1c and Klotho ligand binding and activation
FGFR1|participates_in|FGFR1c and Klotho ligand binding and activation
FGF23|participates_in|FGFR2c ligand binding and activation
FGFR2|participates_in|FGFR2c ligand binding and activation
FGF23|participates_in|Signaling by activated point mutants of FGFR3
FGFR3|participates_in|Signaling by activated point mutants of FGFR3
FGF23|participates_in|FGFR4 ligand binding and activation
FGFR4|participates_in|FGFR4 ligand binding and activation
FGF23|participates_in|PI3K Cascade
COL3A1|participates_in|Extracellular matrix organization
COL3A1|causes or contributes to condition|Extrahepatic cholestasis
COL1A1|causes or contributes to condition|Extrahepatic cholestasis
COL1A1|participates_in|Extracellular matrix organization
